Your browser doesn't support javascript.
IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection.
Villegas, Carolina; Poza, María; Talayero, Paloma; Teller, José Manuel Caro; Zafra, Denis; Garcia, Cristina; Vera, Elena; Hidalgo, Marta; Lopez, Nieves; Cuellar, Clara; Zamanillo, Irene; Íñiguez, Rodrigo; Paz-Artal, Estela; Aguado, José M; Martinez-Lopez, J.
  • Villegas C; Hematology Department Hospital 12 de Octubre, i+12, Universidad Complutense, CNIO, CIBERONC, Madrid, Spain.
  • Poza M; Hematology Department Hospital 12 de Octubre, i+12, Universidad Complutense, CNIO, CIBERONC, Madrid, Spain.
  • Talayero P; Immunology Department, Hospital Universitario "12 de Octubre," Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Universidad Complutense, Madrid, Spain.
  • Teller JMC; Pharmacy Department Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Universidad Complutense, Madrid, Spain.
  • Zafra D; Hematology Department Hospital 12 de Octubre, i+12, Universidad Complutense, CNIO, CIBERONC, Madrid, Spain.
  • Garcia C; Hematology Department Hospital 12 de Octubre, i+12, Universidad Complutense, CNIO, CIBERONC, Madrid, Spain.
  • Vera E; Hematology Department Hospital 12 de Octubre, i+12, Universidad Complutense, CNIO, CIBERONC, Madrid, Spain.
  • Hidalgo M; Hematology Department Hospital 12 de Octubre, i+12, Universidad Complutense, CNIO, CIBERONC, Madrid, Spain.
  • Lopez N; Hematology Department Hospital 12 de Octubre, i+12, Universidad Complutense, CNIO, CIBERONC, Madrid, Spain.
  • Cuellar C; Hematology Department Hospital 12 de Octubre, i+12, Universidad Complutense, CNIO, CIBERONC, Madrid, Spain.
  • Zamanillo I; Hematology Department Hospital 12 de Octubre, i+12, Universidad Complutense, CNIO, CIBERONC, Madrid, Spain.
  • Íñiguez R; Hematology Department Hospital 12 de Octubre, i+12, Universidad Complutense, CNIO, CIBERONC, Madrid, Spain.
  • Paz-Artal E; Immunology Department, Hospital Universitario "12 de Octubre," Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Universidad Complutense, Madrid, Spain.
  • Aguado JM; Hematology Department Hospital 12 de Octubre, i+12, Universidad Complutense, CNIO, CIBERONC, Madrid, Spain.
  • Martinez-Lopez J; Unit of Infectious Diseases, Hospital Universitario "12 de Octubre," Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Universidad Complutense, Madrid, Spain.
Ann Hematol ; 99(12): 2953-2956, 2020 12.
Article in English | MEDLINE | ID: covidwho-612944
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Severity of Illness Index / Receptors, Interleukin-1 / Hematologic Neoplasms / Interleukin 1 Receptor Antagonist Protein / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Ann Hematol Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: S00277-020-04160-w

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Severity of Illness Index / Receptors, Interleukin-1 / Hematologic Neoplasms / Interleukin 1 Receptor Antagonist Protein / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Ann Hematol Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: S00277-020-04160-w